Junlin Yao

Sir Run Run Shaw Hospital
Hangzhou, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 22 publications

Concomitant Medications Alter Clinical Outcomes in Patients with Advanced Digestive Tract Cancer Receiving PD-1 Checkpoint Inhibitors Combined with Antiangiogenetic Agents.

Concomitant Medications Alter Clinical Outcomes in Patients with Advanced Digestive Tract Cancer Receiving PD-1 Checkpoint Inhibitors Combined with Antiangiogenetic Agents.

Journal: Journal of gastrointestinal cancer

Published: July 20, 2024

Integrated Analysis Identifies DPP7 as a Prognostic Biomarker in Colorectal Cancer.

Integrated Analysis Identifies DPP7 as a Prognostic Biomarker in Colorectal Cancer.

Journal: Cancers

Published: July 05, 2023

The diagnosis and treatment for a patient with cancer of unknown primary: A case report.

The diagnosis and treatment for a patient with cancer of unknown primary: A case report.

Journal: Frontiers in genetics

Published: October 31, 2022

Efficacy and safety of PD‑1 inhibitor plus antiangiogenic treatment in patients with unresectable biliary tract cancer: A multicenter retrospective study.

Efficacy and safety of PD‑1 inhibitor plus antiangiogenic treatment in patients with unresectable biliary tract cancer: A multicenter retrospective study.

Journal: Experimental and therapeutic medicine

Published: October 16, 2022

TMP195 Exerts Antitumor Effects on Colorectal Cancer by Promoting M1 Macrophages Polarization.

TMP195 Exerts Antitumor Effects on Colorectal Cancer by Promoting M1 Macrophages Polarization.

Journal: International journal of biological sciences

Published: March 26, 2022

Efficacy and safety of PD-1 inhibitor combined with antiangiogenic therapy for unresectable hepatocellular carcinoma: A multicenter retrospective study.

Efficacy and safety of PD-1 inhibitor combined with antiangiogenic therapy for unresectable hepatocellular carcinoma: A multicenter retrospective study.

Journal: Cancer medicine

Published: December 15, 2021

CD3+CD4-CD8- (Double-Negative) T Cells in Inflammation, Immune Disorders and Cancer.

CD3+CD4-CD8- (Double-Negative) T Cells in Inflammation, Immune Disorders and Cancer.

Journal: Frontiers in immunology

Published: November 16, 2021

A Novel Nutrition-Based Nomogram to Predict Prognosis After Curative Resection of Gastric Cancer.

A Novel Nutrition-Based Nomogram to Predict Prognosis After Curative Resection of Gastric Cancer.

Journal: Frontiers in nutrition

Published: February 05, 2021

Corrigendum to "Cyclosporine A sensitizes human non-small cell lung cancer cells to gefitinib through inhibition of STAT3" [Canc Lett 379 (2016) 124-133].

Corrigendum to "Cyclosporine A sensitizes human non-small cell lung cancer cells to gefitinib through inhibition of STAT3" [Canc Lett 379 (2016) 124-133].

Journal: Cancer letters

Published: August 22, 2020

Efficacy and safety of combined immunotherapy and antiangiogenic therapy for advanced non-small cell lung cancer: A two-center retrospective study.

Efficacy and safety of combined immunotherapy and antiangiogenic therapy for advanced non-small cell lung cancer: A two-center retrospective study.

Journal: International immunopharmacology

Published: August 12, 2020

Targeting late-stage non-small cell lung cancer with a combination of DNT cellular therapy and PD-1 checkpoint blockade.

Targeting late-stage non-small cell lung cancer with a combination of DNT cellular therapy and PD-1 checkpoint blockade.

Journal: Journal of experimental & clinical cancer research : CR

Published: November 26, 2018

Human double negative T cells target lung cancer via ligand-dependent mechanisms that can be enhanced by IL-15.

Human double negative T cells target lung cancer via ligand-dependent mechanisms that can be enhanced by IL-15.

Journal: Journal for immunotherapy of cancer

Published: July 23, 2018

Showing 1-12 of 22

Last Updated: 09/26/2026